Esofagitis eosinofílica

Castaño R, Rivera J, Diazgranados L, Baena JD, Puerta Botero JE, Cadavid I, Álvarez O. Esofagitis eosinofílica y diferencias clínicas, endoscópicas y terapéuticas entre adolescentes y adultos. Revista. colomb. Gastroenterol. 2024;39(4):376-385. https://doi.org/10.22516/25007440.1137

Juliao-Baños F, Lúquez-Mindiola A. Esofagitis eosinofílica: estado del arte en 2024. Revista. colomb. Gastroenterol. 2024;39(4):435-446. https://doi.org/10.22516/25007440.1276

Chang NC, Thakkar KP, Ketchem CJ, Eluri S, Reed CC, Dellon ES. A Gap in Care Leads to Progression of Fibrosis in Eosinophilic Esophagitis Patients. Clin Gastroenterol Hepatol. 2022;20(8):1701-1708.e2. https://doi.org/10.1016/j.cgh.2021.10.028

Wang R, Hirano I, Doerfler B, Zalewski A, Gonsalves N, Taft T. Assessing Adherence and Barriers to Long-Term Elimination Diet Therapy in Adults with Eosinophilic Esophagitis. Dig Dis Sci. 2018;63(7):1756-1762. https://doi.org/10.1007/s10620-018-5045-0

Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, et al. AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis. Gastroenterology. 2020;158(6):1776-1786. https://doi.org/10.1053/j.gastro.2020.02.038

Barchi A, Mandarino FV, Dell’Anna G, Fasulo E, Yacoub M, Albarello L, et al. OC.18.11: long-term outcomes of maintenance therapy in adult and pediatric eosinophilic esophagitis: a systematic review and metanalysis. Digest Liver Dis. 2024;56:S219-20. https://doi.org/10.1016/s1590-8658(24)00556-5

Mayerhofer C, Kavallar AM, Aldrian D, Lindner AK, Müller T, Vogel GF. Efficacy of Elimination Diets in Eosinophilic Esophagitis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2023;21(9):2197-2210.e3. https://doi.org/10.1016/j.cgh.2023.01.019

Kliewer KL, Gonsalves N, Dellon ES, Katzka DA, Abonia JP, Aceves SS, et al. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol. 2023;8(5):408-421. https://doi.org/10.1016/S2468-1253(23)00012-2

Safroneeva E, Rossel JB, Saner C, Biedermann L, Kreienbuehl A, Greuter T, et al. Real-life effectiveness of swallowed topical steroids, proton pump inhibitors, and elimination diets: results from the swiss eosinophilic esophagitis cohort study. Gastroenterology. 2024;166(5):S-421. https://doi.org/10.1016/s0016-5085(24)01444-6

Henderson AF, Khan SM, Hornung LN, Mukkada VA, Kalkwarf HJ. Prevalence and Predictors of Compromised Bone Mineral Density in Pediatric Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2020;71(6):764-770. https://doi.org/10.1097/MPG.0000000000002866

Lucendo AJ, Miehlke S, Bredenoord A, Schoepfer AM, Attwood SE, Biedermann L, et al. Sa1283 maintenance treatment with orodispersible budesonide is not associated with changes in bone biomarkers in adult patients with eosinophilic esophagitis (eoe): results from a randomized, double-blind, placebo-controlled, 48-week trial (study BUL-2/EER). Gastroenterology. 2024;166(5):S-417. https://doi.org/10.1016/s0016-5085(24)01435-5

Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, et al. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology. 2020;158(6):1789-1810.e15. https://doi.org/10.1053/j.gastro.2020.02.039